Cargando...
Pregnancy outcomes following maternal treatment with rituximab prior to or during pregnancy: a case series
OBJECTIVE: Rituximab is a CD20-directed cytolytic antibody used for non-Hodgkin lymphoma, chronic lymphocytic leukaemia and RA, and off label for JIA, multiple sclerosis and lupus. Owing to concerns about infant B cell depletion, the manufacturer recommends avoidance of rituximab throughout pregnanc...
Gardado en:
| Publicado en: | Rheumatol Adv Pract |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Oxford University Press
2021
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7819866/ https://ncbi.nlm.nih.gov/pubmed/33521513 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rap/rkaa074 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|